Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Mahmoud A Ali1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Sahin Lacin1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Reham Abdel-Wahab1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2 Department of Clinical Oncology, Assiut University, Assiut, Egypt

Mark Uemura1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Manal Hassan1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Asif Rashid3 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dan G Duda4 Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

Ahmed O Kaseb1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]

show all

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Citations (4)

Articles from other publishers (4)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date